Skip to main content

Together we are beating cancer

Donate now

For Researchers

Showing 12 out of 391 results

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research. In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

by Cancer Research UK | Analysis | 24 January 2023

24 January 2023

This entry is part 5 of 17 in the series Research Integrity
%postcontent%

This episode features Dr Simon Boulton. Simon is a leader in the field of DNA damage sensing, repair and telomere maintenance. He talks about the dawn of the field of DNA damage repair, why an entrepreneurial approach to your research is so valuable and the importance of venture capital in the innovation landscape. This episode features Dr Simon Boulton. Simon is a leader in the field of DNA damage sensing, repair and telomere maintenance. He talks about the dawn of the field of DNA damage repair, why an entrepreneurial approach to your research is so valuable and the importance of venture capital in the innovation landscape.

by Phil Prime | Podcast | 20 January 2023

20 January 2023

This entry is part 8 of 9 in the series Cancer Research Matters - series 1
%postcontent%
  • For Researchers

Time to get stratified

As genetic screening becomes routine for cancer detection and treatment, we need to ensure this can be delivered at scale and quickly within a national health system. As genetic screening becomes routine for cancer detection and treatment, we need to ensure this can be delivered at scale and quickly within a national health system.

by Cancer Research UK | Analysis | 10 January 2023

10 January 2023

The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects... The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects...

by Cancer Research UK | In depth | 15 December 2022

15 December 2022

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research. In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

by Cancer Research UK | Analysis | 7 December 2022

7 December 2022

This entry is part 6 of 17 in the series Research Integrity
%postcontent%
Simon-Boulton-and-Kairbaan-Hodivala-Dilke

We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs. We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs.

by Phil Prime | Interview | 22 November 2022

22 November 2022

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research. In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

by Cancer Research UK | Analysis | 14 November 2022

14 November 2022

This entry is part 7 of 17 in the series Research Integrity
%postcontent%
This entry is part 1 of 10 in the series Diversity in research
%postcontent%

This episode features our Chief Clinician Professor Charles Swanton. He talks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx. This episode features our Chief Clinician Professor Charles Swanton. He talks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx.

by Phil Prime | Podcast | 1 November 2022

1 November 2022

This entry is part 7 of 9 in the series Cancer Research Matters - series 1
%postcontent%
This entry is part 2 of 10 in the series Diversity in research
%postcontent%

Developing treatments and diagnostics from your research really is the best way to create patient impact says radiation biologist Professor Catharine West... Developing treatments and diagnostics from your research really is the best way to create patient impact says radiation biologist Professor Catharine West...

by Phil Prime | Interview | 17 October 2022

17 October 2022